EFFICACY AND SAFETY OF ORAL DEUCRICTIBANT FOR PROPHYLAXIS AND ON-DEMAND TREATMENT OF ATTACKS IN ACQUIRED ANGIOEDEMA WITH C1 INHIBITOR DEFICIENCY: CREAATE PHASE 3 TRIAL DESIGN